Trial
NCT03206788
Losartan and Inflammation in Cystic Fibrosis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
University of Alabama at Birmingham; Children's Hospital Medical Center, Cincinnati; University of Kansas Medical Center; Cystic Fibrosis Foundation
Condition
Cystic Fibrosis
Intervention
Losartan
Why stopped
due to slow enrollment and approval of the Trikafta for CF patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-11-27